
Collate
Collate uses AI to create and streamline paperwork for diagnostic, medical device, and drug development companies—from concept to market. Our mission is to accelerate life-saving innovations by creating accurate documentation for the life sciences industry.
Collate raised $95M in a Series A round announced June 3, 2026, according to forbes.com. Across 2 sourced rounds it has raised $125M in total. Investors in that round: Redpoint Ventures.
Raise history
- First seen by Recent Fundingvia startups.gallery
- Series A · $95M
RRedpoint Ventures (lead)
Source: forbes.com (startups.gallery listing) - Seed · $30M
RRedpoint Ventures (lead)
Source: forbes.com (startups.gallery listing)
Investors
Related other companies
QQuartermaster$140M · Sep 28, 2026
SSnorkel AI$350M · Sep 23, 2026
EEnveda$311M · Sep 23, 2026
HHeidi Health$100M · Sep 22, 2026FFirecrawl$75M · Sep 22, 2026
CCorridor$25M · Sep 21, 2026- JJack & Jill$40M · Sep 19, 2026
- MMithr Inc.$20M · Sep 19, 2026
Every amount links to the page it came from. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/collate.